Clinical Trial Update: Stem Cells Treatment for Bilateral Limbic Associated Keratopathy (HULPOFT) [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial update for a stem cell therapy targeting keratopathy (HULPOFT), with the current status listed as unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Keratopathy

Drugs mentioned

• HULPOFT stem cell therapy

Snippet

Sponsor: Instituto de Investigación Hospital Universitario La Paz | Conditions: Keratopathy | Phase 2 | Status: UNKNOWN